VaIN and HPV: Understanding Cellular Changes
At a Glance
VaIN is not vaginal cancer but a range of abnormal vaginal cell changes often linked to persistent high-risk HPV. VaIN 1 commonly regresses with monitoring, while VaIN 2 or 3 is precancerous and usually needs treatment plus long-term follow-up.
One important potential cause for a white patch in the vagina is Vaginal Intraepithelial Neoplasia, or VaIN. While the name sounds complex, it simply describes a condition where the cells in the lining of the vagina have begun to change in a way that could eventually lead to cancer if left alone [1].
It is important to understand that VaIN is not cancer; it is a spectrum of cellular changes. Because it is strongly associated with the Human Papillomavirus (HPV), managing it involves understanding both the cellular changes and the viral infection [2][3].
The Role of HPV
HPV is a very common virus that most people encounter at some point. While the body’s immune system usually clears the virus, sometimes “high-risk” types of HPV persist in the vaginal tissue [1]. This persistent infection can cause the cells to transform, leading to the white plaques seen during an exam.
Studies show that high-risk HPV is strongly associated with VaIN, particularly in high-grade cases [4]. Because this virus can affect the entire lower genital tract, it is common for VaIN to occur alongside similar changes on the cervix or vulva [5]. If you have a history of abnormal Pap smears or cervical “precancer,” your risk for developing VaIN is higher [6].
An Important Note on HPV: There is no routine medical treatment that eradicates an existing HPV infection; treatment is directed at removing the abnormal cells the virus has caused. Clearing the virus itself relies on your immune system. Finding out you have HPV does not tell you when you acquired it, nor does it imply recent transmission or infidelity. If you smoke, quitting is one of the most effective ways to help your immune system fight the virus. You can also ask your doctor if the HPV vaccine is appropriate for you.
Understanding the Grades of VaIN
Not all white patches are the same. Your pathology report will assign a “grade” to the VaIN, which tells your doctor how much the cells have changed and how likely they are to progress [1].
- VaIN 1 (vLSIL): This is considered “low-grade.” The cells look only slightly abnormal. In many cases, VaIN 1 is simply a sign of an active HPV infection that your body is currently fighting, rather than a true precancer [7].
- VaIN 2 and 3 (vHSIL): These are “high-grade” changes. The cells look more significantly altered and occupy more of the vaginal lining. These grades represent true precancerous precursors that are less likely to go away on their own and have a meaningful risk of becoming invasive cancer over time [7][1].
Management: Observation vs. Treatment
Current international guidelines (from organizations like ESGO and ISSVD) recommend different paths based on the grade of the lesion [1].
Managing VaIN 1 (Low-Grade)
For VaIN 1, the most common recommendation is expectant management, which is a medical way of saying “watching and waiting” [1]. This is because low-grade lesions have a high rate of spontaneous regression, meaning they often disappear without any medical intervention as the immune system clears the virus [8].
Managing VaIN 2-3 (High-Grade)
Because VaIN 2 and VaIN 3 carry a higher risk of progression, active treatment is usually recommended [1]. The goal is to remove or destroy the abnormal cells while preserving the function of the vagina.
- Laser Ablation: A CO2 laser is used to vaporize the abnormal tissue. This is a common choice for multifocal disease once invasive cancer has been ruled out [1].
- Excision: A surgeon removes the patch of tissue. This is preferred if the doctor needs to ensure that no invasive cancer is hidden deeper in the tissue [1].
- Topical Therapy: In selected cases, specialist-directed topical treatments may be used [1].
Long-Term Monitoring
Regardless of the grade or treatment, VaIN requires follow-up. The virus can remain in the surrounding tissue, leading to new patches later on [9]. Your care plan will likely include scheduled check-ups using a combination of a visual exam, a Pap-style swab, and an HPV test [1]. Keeping these appointments is the best way to ensure that any new changes are caught early when they are easiest to manage.
Common questions in this guide
Is VaIN the same as vaginal cancer?
What does a VaIN 1 or VaIN 2/3 result mean?
Can VaIN 1 go away without treatment?
What treatments are used for high-grade VaIN?
Can HPV be treated or cured when it causes VaIN?
What follow-up is needed after a VaIN diagnosis or treatment?
Does an HPV diagnosis show when I caught the infection?
Related questions
Get notified when new evidence is published on leukoplakia of vagina.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
Kesic V, Carcopino X, Preti M, et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(4)):446-461 doi:10.1136/ijgc-2022-004213.
PMID: 36958755 - 2
Clinical Characteristics and Detection Sensitivity of Cervical Cancer Screening in Vaginal Intraepithelial Neoplasia.
Chen Y, Chen Q, Xue H, et al.
Journal of lower genital tract disease 2024; (28(2)):137-142 doi:10.1097/LGT.0000000000000793.
PMID: 38109483 - 3
HPV Genotyping by Molecular Mapping of Tissue Samples in Vaginal Squamous Intraepithelial Neoplasia (VaIN) and Vaginal Squamous Cell Carcinoma (VaSCC).
Zhang S, Saito M, Okayama K, et al.
Cancers 2021; (13(13)) doi:10.3390/cancers13133260.
PMID: 34209851 - 4
Human papillomavirus and p16 in squamous cell carcinoma and intraepithelial neoplasia of the vagina.
Bertoli HK, Rasmussen CL, Sand FL, et al.
International journal of cancer 2019; (145(1)):78-86 doi:10.1002/ijc.32078.
PMID: 30561092 - 5
High-grade vaginal intraepithelial neoplasia and recurrence risk: analysis of an Italian regional referral center series.
Monti E, Libutti G, Di Loreto E, et al.
Archives of gynecology and obstetrics 2023; (308(1)):201-206 doi:10.1007/s00404-022-06886-6.
PMID: 36564638 - 6
Human Papillomavirus Genotype Attribution and Integration in High-Grade Vaginal Intraepithelial Neoplasia.
Shen Y, Tang S, Zhou Y, et al.
Journal of lower genital tract disease 2025; (29(1)):60-67 doi:10.1097/LGT.0000000000000850.
PMID: 39620892 - 7
Human Papilloma Virus-Associated Squamous Neoplasia of the Lower Anogenital Tract.
Yang EJ
Surgical pathology clinics 2019; (12(2)):263-279 doi:10.1016/j.path.2019.02.001.
PMID: 31097104 - 8
Non-Excisional therapeutic modalities in vaginal intraepithelial neoplasia.
Freitas G, Costa A
European journal of obstetrics, gynecology, and reproductive biology 2023; (284()):175-179 doi:10.1016/j.ejogrb.2023.03.014.
PMID: 37004357 - 9
Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: a comprehensive analysis of 576 cases.
Kim MK, Lee IH, Lee KH
Journal of gynecologic oncology 2018; (29(1)):e6 doi:10.3802/jgo.2018.29.e6.
PMID: 29185264
This page is for informational purposes only and does not replace professional medical advice. A gynecologist or other qualified clinician should interpret your biopsy and help choose observation, treatment, and follow-up for you.